Atrial Fibrillation & Arrhythmia Overview
Atrial Fibrillation & Arrhythmia Overview
Atrial fibrillation is the commonest sustained arrhythmia: the upper chambers stop contracting in an organised way and the pulse becomes irregular — sometimes racing, sometimes barely noticeable. It matters for two entirely different reasons. The first is what it costs the patient — palpitations, breathlessness, fatigue, a quiet loss of exercise capacity, and in some people nothing at all. The second is what it does to the risk of stroke, which rises whether or not any symptom is ever felt. This guide separates those two threads deliberately, because they are assessed with different tests and answered with different treatments — and because treating the rhythm is not the same act as protecting the brain.
-
24/7
Emergency cardiac cover at both flagship hospitals
-
170
Specialised cardiovascular beds across the two flagship hospitals
-
5
National certifications at the Foshan hospital, including its atrial fibrillation centre
-
124+
Countries and regions our international patients come from
What atrial fibrillation is — an electrical problem, not a plumbing problem
Every heartbeat begins as an electrical signal. A small cluster of cells in the upper right chamber, the sinus node, fires on its own; the impulse then spreads across the two upper chambers — the atria — making them contract, and passes down a single narrow gateway to the ventricles, which contract a moment later. That sequence is what produces a pulse you can feel: a small filling beat, then the main one.
In atrial fibrillation the sequence breaks down. Instead of one organised wave, several hundred disorganised impulses circulate around the atria each minute, often beginning at the openings through which the pulmonary veins enter the left atrium. The atria stop contracting usefully and simply quiver. The gateway to the ventricles is then bombarded irregularly, so the ventricles beat at an uneven and often fast pace. On an electrocardiogram the pattern is unmistakable; under a finger on the wrist it produces the irregularly irregular pulse that doctors treat as the physical signature of AF.
Two clarifications belong at the start, because both cause real confusion. First, arrhythmia is an umbrella term rather than one disease: it covers rhythms that begin in the atria and rhythms that begin in the ventricles, and those two families carry very different consequences. Atrial fibrillation is the commonest sustained arrhythmia in adults and belongs to the atrial family — which is why it is frightening to live with while rarely being immediately dangerous, whereas some rhythms from the lower chambers are the reverse. Second, an uneven pulse has more than one possible explanation, and working out which one a patient has is the first job of the assessment rather than an assumption to be made from the pulse alone.
One boundary is worth stating plainly, because patients often arrive carrying it: atrial fibrillation is not the same disease as coronary heart disease, heart failure or valve disease. The coronary arteries, the heart muscle and the valves each have their own guides, because each is investigated and treated differently. They also meet frequently — a leaky mitral valve and a weakened muscle both encourage the rhythm, and the rhythm in turn can weaken the muscle — but "my heart has a problem" has several distinct answers, and this guide is about the electrical one.
The spectrum: how the arrhythmias differ in origin and in duration
The family of arrhythmias is sorted along two independent lines: where the rhythm originates, and how long it persists once it starts. The first line separates rhythms that are uncomfortable from rhythms that are dangerous; the second line describes how much the atrium has already changed, and therefore which treatments remain realistic.
| Rhythm | What is happening | What it usually means |
|---|---|---|
| Paroxysmal atrial fibrillation | Episodes that begin on their own and stop on their own, usually within a week and often within a day | The earliest stage, and the one in which the trigger is easiest to identify — the pulmonary vein openings dominate, so isolating them addresses the mechanism directly |
| Persistent atrial fibrillation | The rhythm does not stop by itself and is still present after a week; it ends with treatment such as cardioversion or an ablation | The atrial tissue has begun to remodel, so restoring a normal rhythm is still pursued but the plan is usually larger |
| Long-standing persistent or permanent atrial fibrillation | The rhythm has been continuous for a year or more, or the decision has been made with the patient to stop trying to restore a normal rhythm | Rate control and stroke prevention become the backbone; the label records a shared decision, not a failure |
| Atrial flutter | A single electrical circuit circling the right atrium, usually at around 300 impulses a minute, with the ventricles responding to a regular fraction of that | Sits alongside AF — the same stroke-risk logic applies, the same anticoagulation conversation follows, and the circuit itself is often highly treatable by ablation |
| Supraventricular tachycardia | A short circuit above the ventricles — most often inside the AV node or along an extra pathway — producing attacks that start and stop abruptly and remain regular | Uncomfortable rather than dangerous in most cases; attacks can be stopped by manoeuvres or medicines and cured by a small ablation |
| Ventricular ectopics and ventricular tachycardia | Extra beats, or fast rhythms, arising in the ventricles themselves — the pumping chambers | A different family with a different urgency: they are assessed for underlying structural disease, and a sustained ventricular rhythm is an emergency rather than an outpatient question |
Two questions run through that table, and keeping them apart prevents most confusion. The first is where the rhythm begins — the atria or the ventricles — because it is the ventricular rhythms that can be immediately life-threatening. The second is how long it lasts, because duration tells you how much the atrial tissue has already changed. Atrial fibrillation is the arrhythmia whose answers move over time: patients drift from paroxysmal to persistent, and a rhythm that has been successfully treated does not always stay treated.
There is also a feedback loop inside the process that shapes everything downstream. An atrium that spends weeks fibrillating loses contractile muscle and gains fibrous tissue, and a stiffer, more fibrous atrium holds on to the rhythm more stubbornly than it did at the start. That is the practical reason clinicians do not simply leave a symptomatic rhythm alone for years, and it is why the label in the table above describes where a patient is now rather than naming a permanent state. The treatments that follow from each label — rate control, rhythm control, ablation, anticoagulation — are compared on the treatment options page.
Two harms that are read separately: what the rhythm costs, and what it risks
Atrial fibrillation is unusual among heart conditions in one respect. How unwell a patient feels, and how dangerous the condition is, are two separate readings taken with different tools. The first is the symptom burden — the cost of the rhythm to daily life: breathlessness on the stairs, a pulse that will not settle at night, a fatigue that has quietly removed the last mile of a walk. That burden is graded rather than guessed at, and the grading exists to make a vague complaint into a concrete conversation; the symptoms page sets out how the grades are described and what each one changes.
The second reading is the risk of stroke, and it has nothing to do with whether anything is felt. When the atria stop contracting as a unit, blood slows and pools in the left atrium — and the place it pools most reliably is a small, blind-ended pouch attached to it, the left atrial appendage. A clot that forms there can leave the heart, travel up the arteries of the neck and lodge in the brain. Most of the clots responsible for strokes in people with atrial fibrillation come from that pouch. The whole process is silent by nature: it does not announce itself with palpitations, and for a substantial number of patients a stroke is the first evidence that the rhythm had ever been abnormal.
Because the two readings are different, they lead to different treatments rather than to one. The symptom reading drives the choice between controlling the rate and restoring a normal rhythm. The stroke reading drives anticoagulation — and that decision is not left to impression. It is structured by a checklist of the factors that raise stroke risk in atrial fibrillation, known by its initials as CHA₂DS₂-VASc, completed for every patient; against it sits a parallel assessment of bleeding risk, because the two are always weighed together. How that assessment runs, and what the letters stand for, belongs to the diagnostic page — and neither score replaces the conversation that follows it.
The third thing assessed is not a score at all but the ground the rhythm is growing in: the size of the atria, the state of the valves, how long the rhythm has been present and how much of the day it occupies. A large, fibrous atrium with a leaking mitral valve and a rhythm continuous for two years is a different starting point from a normal-sized heart whose episodes last an afternoon. That distinction appears in neither score, it is read from the echocardiogram, and it is the honest reason two patients carrying the same diagnosis are offered different plans.
How the assessment is ordered, and why the order matters
The assessment is organised around a single difficulty: atrial fibrillation is intermittent, and a test only finds what happens while it is running. A 24-hour monitor is decisive for a patient whose episodes come most days, and nearly useless for one whose episodes come once a month. That one fact dictates the order of the work — and it is why a normal electrocardiogram in an emergency department does not close the question.
The order matters for a second reason as well. Some rhythms are dangerous within the next hour — a sustained ventricular rhythm, or atrial fibrillation with a very fast rate in a patient who is already unwell — and those are excluded first, before anything elective is planned. Only then does the work turn to characterising the rhythm, describing the heart that carries it, and quantifying the risk it creates.
A 12-lead electrocardiogram taken during symptoms settles it. If no tracing was captured, a description of what the patient felt is a reason to keep looking, not a diagnosis.
The monitoring window is matched to how often the episodes come — a single day, a week, a fortnight, or a small recorder placed under the skin for months.
An echocardiogram answers the questions that change treatment: the size of the atria, the state of the valves, and how well the muscle pumps.
Stroke-risk factors are recorded with bleeding risk beside them, and the reversible drivers — thyroid, blood pressure, sleep apnoea, alcohol — are identified before a plan is made.
Every test answers one question and none of them answers another's. Which tool answers which question — and what each tool cannot do — is set out one by one on the diagnosis page, together with the four things a completed assessment should be able to state.
Why patients travel to China for rhythm treatment
Rhythm treatment is decided from tracings, images and scores, and all three travel well. The electrocardiograms stored on a phone, the echocardiogram report, the monitor printouts and the list of what has already been tried are enough for a cardiology team to form a view before anyone books a flight. What differs between providers is the span of what can be done once the patient is in the room: whether the electrophysiology laboratory, the emergency service and the surgical backup sit under one roof, and how quickly a visiting patient moves from records to a decision.
Our cardiovascular service runs across two flagship hospitals — Fosun Hospital Foshan and Fosun Hospital Guangzhou — with nearly 170 specialised cardiovascular beds, coronary care units and electrophysiology laboratories, and emergency cover around the clock at both. The Foshan hospital holds five national certifications — chest pain, atrial fibrillation, heart failure, cardiac rehabilitation and hypertension — the first hospital in its city to hold them, and the atrial fibrillation centre among them covers precisely the work described on this page: confirming the rhythm, managing rate and rhythm, catheter ablation and pulmonary vein isolation, anticoagulation, and structured follow-up. The Guangzhou hospital obtained national chest pain centre certification in 2025.
For a patient coming from abroad, records reviewed by a cardiology team receive a written opinion within about 48 hours of complete records arriving. With a rhythm problem the useful records are the tracings themselves — the electrocardiograms, the monitor reports, the dates and the duration of the episodes, and any note of what the pulse was doing during them — rather than a summary line that says only "atrial fibrillation". Complete treatment in China typically runs at 30–50% of comparable care in Europe or the United States, we work with more than 30 commercial insurers for direct billing, and our international patients have come from 124 countries and regions. The follow-up that keeps a rhythm stable — medication review, monitoring, rehabilitation — is delivered on site rather than handed over as a leaflet.